Aileron Therapeutics
company
About
Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides.
- 1 - 10
Details
- Last Funding Type
- Post-IPO Secondary
- Last Funding Money Raised
- $35.90M
- Industries
- Biopharma,Biotechnology,Therapeutics
- Founded date
- Jan 1, 2005
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Aileron Therapeutics is a biopharmaceutical company that develops a class of drugs called Stapled Peptides. Stapled Peptides represent the first general solution for modulating intracellular protein-protein interactions that are critical control points to nearly all functions of a cell.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$35.90M
Aileron Therapeutics has raised a total of
$35.90M
in funding over 2 rounds. Their latest funding was raised on
Jan 6, 2021 from a Post-IPO Secondary round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 6, 2021 | Post-IPO Secondary | $35.90M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Aileron Therapeutics is funded by 1 investors.
Maven Investment Partners US
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Post-IPO Secondary |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
